Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 21, 2017; 23(7): 1189-1202
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1189
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1189
Table 2 Different expressed mRNAs enriched by KOBAS
Term | Database | P value | Input gene symbols |
Gastric cancer | KEGG DISEASE | 0.0016 | DCC, CD44, CDH1, VEGFC, EGF, TGFA |
Skin diseases | KEGG DISEASE | 0.0078 | DSP, TGM1, CCL5, IL31RA, SPINK5, HLA, FERMT1, KRT14, CTSC, COL17A1, LAMA3, REEP1, RIN2, ALOXE3, ABCC6, WNT10A, FBLN5 |
Skin and soft tissue diseases | KEGG DISEASE | 0.0078 | DSP, TGM1, CCL5, IL31RA, SPINK5, HLA, FERMT1, KRT14, CTSC, COL17A1, LAMA3, REEP1, RIN2, ALOXE3, ABCC6, WNT10A, FBLN5 |
Macular degeneration | KEGG DISEASE | 0.0140 | C3, FBLN5, CFH, TLR4 |
Cancers of the digestive system | KEGG DISEASE | 0.0439 | DCC, CD44, CDH1, VEGFC, EGF, TGFA |
Familial thoracic aortic aneurysm and dissection (TAAD) | KEGG DISEASE | 0.0459 | MYLK, TGFBR1 |
Hypomagnesemia | KEGG DISEASE | 0.0459 | TRPM6, EGF |
Multiple epiphyseal dysplasia (MED) | KEGG DISEASE | 0.0459 | COL9A3, MATN3 |
Transient neonatal diabetes mellitus (TNDM) | KEGG DISEASE | 0.0459 | PLAGL1, ZFP57 |
Non-syndromic autosomal dominant mental retardation | KEGG DISEASE | 0.0461 | EPB41L1, DOCK8, PACS1, SMARCA4 |
Cardiac hypertrophy | NHGRI GWAS Catalog | 0.0028 | PLXNA2, GRIK2, COL17A1, JAG1, SNAP25, BTBD3, SLX4IP |
Response to fenofibrate (adiponectin levels) | NHGRI GWAS Catalog | 0.0046 | OAS2, PMEPA1, SHANK2, SCUBE1, SLC30A4, PCK1 |
Complement C3 and C4 levels | NHGRI GWAS Catalog | 0.0094 | HLA, CFHR3, CFH, C3 |
Neutrophil count | NHGRI GWAS Catalog | 0.0119 | PLCB4, TGFA, FGGY, PDGFD, PSD3 |
Nephropathy(idiopathic membranous) | NHGRI GWAS Catalog | 0.0137 | HLA, ITGB6, PLA2R1 |
Sleep duration | NHGRI GWAS Catalog | 0.0195 | PLLP, TMC5, ADAMTS14 |
Airflow obstruction | NHGRI GWAS Catalog | 0.0259 | HYKK, LEF1, SERPINB8, GPR126, MAP3K13, PTPRD |
Cystic fibrosis severity | NHGRI GWAS Catalog | 0.0265 | HLA, EHF, AHRR |
Metabolite levels (5-HIAA/ MHPG Ratio) | NHGRI GWAS Catalog | 0.0265 | PIEZO2, ROBO2, ADAM12 |
Bronchopulmonary dysplasia | NHGRI GWAS Catalog | 0.0296 | PLXDC2, ZNF770, SPOCK1, TRPS1, RASGRF1, HIVEP3 |
Major depressive disorder | NHGRI GWAS Catalog | 0.0346 | PCLO, SLC6A15, ENOX1, SYPL2, IGFBP1, IGFBP3, C12orf5, ATXN1, PIEZO2, TRPS1, RASGEF1B, FGF12, KCNH5 |
IgA nephropathy | NHGRI GWAS Catalog | 0.0346 | HLA, ACOXL, TNFSF13 |
Pulmonary function decline | NHGRI GWAS Catalog | 0.0368 | MUSK, CSMD1, RORA, FLRT2 |
Palmitic acid (16:0) plasma levels | NHGRI GWAS Catalog | 0.0368 | SCD, CNN3, GRIK2, PTPRD |
Male-pattern baldness | NHGRI GWAS Catalog | 0.0439 | AUTS2, EDA2R, AR |
Response to citalopram treatment | NHGRI GWAS Catalog | 0.0439 | LAMA1, RORA, EGFLAM |
Hyperlipidemia | FunDO | 0.0050 | IRS1, CCL5, C3, PAPPA, TXNIP, APOC1, F3, SCD |
Thrombocytopenia | FunDO | 0.0068 | GATA1, CCL5, ITGB3, IL11, CXCL8, MPL |
Fibromyalgia | FunDO | 0.0126 | MAOB, CXCL8, BDNF, IGFBP3 |
Cirrhosis | FunDO | 0.0209 | RBP4, KRT18, IGFBP3, KRT8, EGF, F3, FGF2IGFBP1 |
Hepatitis C | FunDO | 0.0321 | CD274, CCL5, RBP4, MKI67, CXCL8, KRT18, TLR4, KRT8, FGF2 |
Thalassemia | FunDO | 0.0345 | LCN2, CXCL8, ANK2, KIR3DL1, MUC1 |
Gingival overgrowth | FunDO | 0.0417 | EDN1, IL15, FGF7 |
Pulmonary fibrosis | FunDO | 0.0474 | CSF1, BDNF, MMP7, EDN1, CCL5, ERBB3 |
Ovary cancer | FunDO | 0.0477 | LCN2, IL15, CXCL8, FGF7, CASP1 |
Esophageal tumor | FunDO | 0.0477 | CD274, TSPAN8, FRAT1, PDCD1LG2, FGF7 |
Hyperlipidemia | GAD | 0.0093 | CCL5, HLA, CXCL8, CD22, TNFRSF1B, CD19 |
Thrombocytopenia | GAD | 0.0114 | CSMD1, DOCK4, GALNTL6, SOBP, PLXDC2, SESN3, ADAMTS5, EHF, TMC5, LPL, CD109, FAM117B, PDE1C, TAGLN, PTN, FGD4, DYNC2H1, GNG4, MUSK, FBLN5, CCDC54, TTC9, PMEPA1, TLR4, ANK3, EDA2R, APOC1, BMP2, TOX3, NRG1, ITPK1, PTPRD, KLF6, PAM, PTPRU, LEPR, IKZF2, LHX5, MCTP2, ANKRD50, SEMA6D, PLXNA2, DPYD, GRIK2, SRGAP3, ACOXL, TDRKH, FAM135B, VEGFC, CHST2 |
Fibromyalgia | GAD | 0.0136 | GLI3, CELF2, VWA3B, PLXDC2, EDNRA, EDN1, JUN, DOCK8, DCLK2, BTBD3, DCN, CD74, EGFLAM, TLL1, TLR4, BMP2, PTPRD, ANK2, PTPRU, JADE2, IGF2BP2, PAPPA, DOCK2, KLK4, FAM49A, RGS3, AATK, FN1, IGSF10, NCOA7, SCIN, TNS1, FAM135B, MUC16, ADAM19, ATXN1, MTUS2, NXNL2, KCNQ3, ANPEP, CDH2 |
Cirrhosis | GAD | 0.0204 | IRS1, CCL5, ITGB3, NPR1, NPR3, APOC1, LPL |
Hepatitis C | GAD | 0.0258 | DPYD, CELF4, CELF2, FAM117B, TDRKH, LPCAT4, FBLN5, SOBP, PMEPA1, CSMD1, STOX1, CACNB2, CADM1, VEGFC, SLC7A11, LPL, CD109, MCTP2, SLC24A2, PTPRD, ITPK1 |
Thalassemia | GAD | 0.0362 | MCTP2, PSD3, CCDC54, ROBO2, ELOVL6 |
Gingival overgrowth | GAD | 0.0419 | PLXNA2, ATXN1, IGF2BP2, ABCA13, FN1 |
Pulmonary fibrosis | GAD | 0.0420 | CREG2, GALNTL6, LINC01550, KIF16B, SH3BGR, TRPS1, PDE1C, NCKAP5, TNFRSF21, RYR3, MAGEC2, EDIL3, CXCL16, MCF2, DTD1, GPC5, KLF6, IKZF2, KCNH5, AJAP1, BTBD3, PHACTR2, ITPK1, IGSF10, SRGAP3, C12orf75, ABI3BP, FOS, SCUBE1 |
Ovary cancer | GAD | 0.0426 | CELF4, TRPS1, TWIST1, PQLC2L, MAL2, PSD3, RCAN2, SUPT3H, TGFA, TMEM131L, HIVEP3, CSMD1, ROBO2, CCDC54, PRNP, APOC1, HRK, GPC5, AR, FN1, ABCA13, F2RL2, KLF6, IGF2BP2, LEPREL1, GNG4, SNAP25, MCTP2, FAM49A, ANKRD50, CACNA2D1, PLXNA2, ELOVL6, RUNX2, SCN8A, ATXN1, ID2, SLC24A2, CMTM7, LINGO2 |
Esophageal tumor | GAD | 0.048 | CACNA2D1, SLC46A3, CHST2, PKDCC, PPID, CDH2 |
- Citation: Xie XQ, Zhao QH, Wang H, Gu KS. Dysregulation of mRNA profile in cisplatin-resistant gastric cancer cell line SGC7901. World J Gastroenterol 2017; 23(7): 1189-1202
- URL: https://www.wjgnet.com/1007-9327/full/v23/i7/1189.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i7.1189